List of serched triples

A total of 22252 records found

#18072 middle Confidence
Subject: TCC (Tumor type)
shows_positive_expression_of
Object: EMA (epithelial cell differentiation antigen)
Original: Both TCC and RCC#were positive for#EMA and cytokeratins CAM-5.2/ AE1/AE3/ MAK-6
🏥 Diagnostic significance 📄 PMID: 7506117
#18071 middle Confidence
Subject: Nucleolin_expression (Protein expression status)
is_prognostic_factor_for
Object: overall_survival (Survival)
Original: Nucleolin expression#is a prognostic factor for#overall survival in stage II PDA
🏥 Prognostic value 📄 PMID: 20628027
#18070 middle Confidence
Subject: Nucleolin (Ribosome-associated proteins)
is_upregulated_in
Object: ductal_epithelial_cell (Epithelial cells)
Original: Nucleolin expression#was higher in#PDAs and PDA cell lines than in nonneoplastic ductal epithelial cells
🏥 not_specified 📄 PMID: 20628027
#18069 middle Confidence
Subject: Nucleolin (Ribosome-associated proteins)
is_upregulated_in
Object: PDA_cell_line (Tumor cell lines)
Original: Nucleolin expression#was higher in#PDAs and PDA cell lines than in nonneoplastic ductal epithelial cells
🏥 not_specified 📄 PMID: 20628027
#18068 middle Confidence
Subject: Nucleolin (Ribosome-associated proteins)
is_upregulated_in
Object: PDA (Tumor type)
Original: Nucleolin expression#was higher in#PDAs and PDA cell lines than in nonneoplastic ductal epithelial cells
🏥 not_specified 📄 PMID: 20628027
#18067 middle Confidence
Subject: positive_cells (Cell phenotype)
occurred_in
Object: patients_with_grade_I_transitional_cell_carcinomas (Patient population)
Original: positive cells#occurred in#62% of patients with grade I transitional cell carcinomas
🏥 Diagnosis/grading 📄 PMID: 6697294
#18066 middle Confidence
Subject: sharply_angulated_nuclear_rims (Nuclear morphology)
included_in
Object: criteria_for_malignancy (Diagnostic criteria)
Original: Criteria for malignancy#included#sharply angulated nuclear rims
🏥 Diagnostic significance 📄 PMID: 3076105
#18065 middle Confidence
Subject: Screening_technique (Diagnostic techniques)
identified
Object: malignant_lesions (Disease phenotype)
Original: Screening technique#identified#all malignant lesions
🏥 diagnosis 📄 PMID: 2408406
#18064 middle Confidence
Subject: tumor (Tumor)
displayed
Object: prominent_and_diffuse_squamous_differentiation (Differentiation phenotype)
Original: one tumor#displayed#prominent and diffuse squamous differentiation
🏥 not_specified 📄 PMID: 9355232
#18063 middle Confidence
Subject: patients (patient)
survived
Object: at_least_9_years_without_metastasis (Survival)
Original: patients#survived#at least 9 years without metastasis development
🏥 Prognosis 📄 PMID: 11328722
#18062 middle Confidence
Subject: patient (Patient characteristics)
diagnosed_with
Object: rare_peripheral_leukemic_presentation (Disease phenotype)
Original: Patient#was diagnosed with#ALCL with a rare peripheral leukemic presentation
🏥 Diagnostic significance 📄 PMID: 18776764
#18061 middle Confidence
Subject: AML_with_erythroid_differentiation (Tumor subtype)
highlights
Object: need_for_immunohistochemical_profiles (Immunohistochemistry analysis requirements)
Original: AMLs with erythroid differentiation#highlight#the need for differential diagnosis and immunohistochemical profiles
🏥 Diagnostic significance 📄 PMID: 20954271
#18060 middle Confidence
Subject: AML_with_erythroid_differentiation (Tumor subtype)
highlights
Object: need_for_differential_diagnosis (Clinical diagnostic needs)
Original: AMLs with erythroid differentiation#highlight#the need for differential diagnosis and immunohistochemical profiles
🏥 Diagnostic significance 📄 PMID: 20954271
#18059 middle Confidence
Subject: Hematopoietic neoplasm (Tumor type)
is_involved_in
Object: pleural_effusion_cases (Clinical Cases)
Original: Hematopoietic neoplasm#is involved in#a minority of pleural effusion cases
🏥 Diagnostic significance 📄 PMID: 20954271
#18058 middle Confidence
Subject: Malignant_cells (Tumor cells)
are_characterized_by
Object: prominent_nucleoli (Nuclear characteristics)
Original: Malignant cells#are characterized by#clear cytoplasm/ vesicular nuclei/ and prominent nucleoli
🏥 diagnosis 📄 PMID: 9407212
#18057 middle Confidence
Subject: Malignant_cells (Tumor cells)
are_characterized_by
Object: vesicular_nuclei (Nuclear characteristics)
Original: Malignant cells#are characterized by#clear cytoplasm/ vesicular nuclei/ and prominent nucleoli
🏥 diagnosis 📄 PMID: 9407212
#18056 middle Confidence
Subject: Malignant_cells (Tumor cells)
are_characterized_by
Object: clear_cytoplasm (Cell morphology)
Original: Malignant cells#are characterized by#clear cytoplasm/ vesicular nuclei/ and prominent nucleoli
🏥 diagnosis 📄 PMID: 9407212
#18055 middle Confidence
Subject: RDD_histiocytes (Histiocytes)
are_characterized_by
Object: voluminous_cytoplasm_with_engulfment_of_inflammatory_cells (Cell morphology)
Original: RDD histiocytes#are characterized by#enlarged round to oval nuclei/ distinct nucleoli/ and voluminous cytoplasm with engulfment of inflammatory cells
🏥 diagnosis 📄 PMID: 37167084
#18054 middle Confidence
Subject: RDD_histiocytes (Histiocytes)
are_characterized_by
Object: distinct_nucleoli (Nuclear characteristics)
Original: RDD histiocytes#are characterized by#enlarged round to oval nuclei/ distinct nucleoli/ and voluminous cytoplasm with engulfment of inflammatory cells
🏥 diagnosis 📄 PMID: 37167084
#18053 middle Confidence
Subject: RDD_histiocytes (Histiocytes)
are_characterized_by
Object: enlarged_round_to_oval_nuclei (Nuclear characteristics)
Original: RDD histiocytes#are characterized by#enlarged round to oval nuclei/ distinct nucleoli/ and voluminous cytoplasm with engulfment of inflammatory cells
🏥 diagnosis 📄 PMID: 37167084